| Popis: |
Fadrozole, an aromatase inhibitor, can masculinize genetic female chickens and high-dose decreases the hatchability. Therefore, it is important to study the growth and development of sex-reversed females after hatch. Chick embryos from a population of CAU3 egg-type were treated with different concentrations of Fadrozole prior to the sexual differentiation at E3.0 (st18). At hatch, the phenotypic sex and genetic sex were identified by vent sexing and genetic diagnosis with CHD1, respectively. Body weight and shank length of sex reversal were tested at 8 and 20 wk, respectively. Testicular development, oviduct and ovarian degeneration were observed and serum concentration of estradiol and testosterone were tested with radioimmunoassay (RIA) at 30 wk. The results showed that body weight and shank length of sex-reversed females were not significantly different between low-dose groups (0.1, 0.3, and 0.5 mg for F1, F2, and F3, respectively) and high-dose groups (1.0 and 1.3 mg for F4 and F5, respectively) (P>0.05). Left and right testes or ovotestes in F2, F3, F4, and F5 groups were heavier than that of in F1 group (P |
Full Text from ScienceDirect